Sentman CL - Search Results

1

Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity.

Cubillos-Ruiz JR, Engle X, Scarlett UK, Martinez D, Barber A, Elgueta R, Wang L, Nesbeth Y, Durant Y, Gewirtz AT, Sentman CL, Kedl R, Conejo-Garcia JR. Cubillos-Ruiz JR, et al. Among authors: sentman cl. J Clin Invest. 2009 Aug;119(8):2231-44. doi: 10.1172/JCI37716. Epub 2009 Jul 13. J Clin Invest. 2009. PMID: 19620771 Free PMC article.

2

Human NK cell IFN-gamma production is regulated by endogenous TGF-beta.

Meadows SK, Eriksson M, Barber A, Sentman CL. Meadows SK, et al. Among authors: sentman cl. Int Immunopharmacol. 2006 Jun;6(6):1020-8. doi: 10.1016/j.intimp.2006.01.013. Epub 2006 Feb 17. Int Immunopharmacol. 2006. PMID: 16644489

3

Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor.

Zhang T, Barber A, Sentman CL. Zhang T, et al. Among authors: sentman cl. Cancer Res. 2006 Jun 1;66(11):5927-33. doi: 10.1158/0008-5472.CAN-06-0130. Cancer Res. 2006. PMID: 16740733

4

NK cell receptors as tools in cancer immunotherapy.

Sentman CL, Barber MA, Barber A, Zhang T. Sentman CL, et al. Adv Cancer Res. 2006;95:249-92. doi: 10.1016/S0065-230X(06)95007-6. Adv Cancer Res. 2006. PMID: 16860660 Review.

5

Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer.

Barber A, Zhang T, DeMars LR, Conejo-Garcia J, Roby KF, Sentman CL. Barber A, et al. Among authors: sentman cl. Cancer Res. 2007 May 15;67(10):5003-8. doi: 10.1158/0008-5472.CAN-06-4047. Cancer Res. 2007. PMID: 17510432

6

Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways.

Zhang T, Barber A, Sentman CL. Zhang T, et al. Among authors: sentman cl. Cancer Res. 2007 Nov 15;67(22):11029-36. doi: 10.1158/0008-5472.CAN-07-2251. Cancer Res. 2007. PMID: 18006849

7

Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free survival and development of host antitumor immunity in murine ovarian cancer.

Barber A, Zhang T, Sentman CL. Barber A, et al. Among authors: sentman cl. J Immunol. 2008 Jan 1;180(1):72-8. doi: 10.4049/jimmunol.180.1.72. J Immunol. 2008. PMID: 18097006

8

Development of a clinical model for ex vivo expansion of multiple populations of effector cells for adoptive cellular therapy.

Meehan KR, Wu J, Webber SM, Barber A, Szczepiorkowski ZM, Sentman C. Meehan KR, et al. Cytotherapy. 2008;10(1):30-7. doi: 10.1080/14653240701762398. Cytotherapy. 2008. PMID: 18202972

9

Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma.

Barber A, Zhang T, Megli CJ, Wu J, Meehan KR, Sentman CL. Barber A, et al. Among authors: sentman cl. Exp Hematol. 2008 Oct;36(10):1318-28. doi: 10.1016/j.exphem.2008.04.010. Epub 2008 Jul 2. Exp Hematol. 2008. PMID: 18599182 Free PMC article.

10

Estradiol regulates MICA expression in human endometrial cells.

Basu S, Pioli PA, Conejo-Garcia J, Wira CR, Sentman CL. Basu S, et al. Among authors: sentman cl. Clin Immunol. 2008 Nov;129(2):325-32. doi: 10.1016/j.clim.2008.07.005. Epub 2008 Aug 26. Clin Immunol. 2008. PMID: 18728002 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters